Literature DB >> 21633691

Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.

Marc De Hert, Dan Cohen, Julio Bobes, Marcelo Cetkovich-Bakmas, Stefan Leucht, David M Ndetei, John W Newcomer, Richard Uwakwe, Itsuo Asai, Hans-Jurgen Möller, Shiv Gautam, Johan Detraux, Christoph U Correll.   

Abstract

Physical disorders are, compared to the general population, more prevalent in people with severe mental illness (SMI). Although this excess morbidity and mortality is largely due to modifiable lifestyle risk factors, the screening and assessment of physical health aspects remains poor, even in developed countries. Moreover, specific patient, provider, treatment and system factors act as barriers to the recognition and to the management of physical diseases in people with SMI. Psychiatrists can play a pivotal role in the improvement of the physical health of these patients by expanding their task from clinical psychiatric care to the monitoring and treatment of crucial physical parameters. At a system level, actions are not easy to realize, especially for developing countries. However, at an individual level, even simple and very basic monitoring and treatment actions, undertaken by the treating clinician, can already improve the problem of suboptimal medical care in this population. Adhering to monitoring and treatment guidelines will result in a substantial enhancement of physical health outcomes. Furthermore, psychiatrists can help educate and motivate people with SMI to address their suboptimal lifestyle, including smoking, unhealthy diet and lack of exercise. The adoption of the recommendations presented in this paper across health care systems throughout the world will contribute to a significant improvement in the medical and related psychiatric health outcomes of patients with SMI.

Entities:  

Keywords:  Physical illness; barriers; health care; health disparities; monitoring and treatment guidelines; physical health; severe mental illness

Year:  2011        PMID: 21633691      PMCID: PMC3104888          DOI: 10.1002/j.2051-5545.2011.tb00036.x

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


  136 in total

1.  Causes of the excess mortality of schizophrenia.

Authors:  S Brown; H Inskip; B Barraclough
Journal:  Br J Psychiatry       Date:  2000-09       Impact factor: 9.319

2.  Physical health of the long-term mentally ill in the community. Is there unmet need?

Authors:  T S Brugha; J K Wing; B L Smith
Journal:  Br J Psychiatry       Date:  1989-12       Impact factor: 9.319

3.  Is second-generation antipsychotic-induced hyperprolactinemia due to biologically active prolactin or to biologically inactive macroprolactin? Results from a prospective study.

Authors:  Alexander Tschoner; Julia Engl; Maria A Rettenbacher; Susanne Kaser; Helmut W Ott; W Wolfgang Fleischhacker; Josef R Patsch; Christoph F Ebenbichler
Journal:  J Clin Psychiatry       Date:  2009-02       Impact factor: 4.384

4.  Disparities in diabetes care: impact of mental illness.

Authors:  Susan M Frayne; Jewell H Halanych; Donald R Miller; Fei Wang; Hai Lin; Leonard Pogach; Erica J Sharkansky; Terence M Keane; Katherine M Skinner; Craig S Rosen; Dan R Berlowitz
Journal:  Arch Intern Med       Date:  2005 Dec 12-26

5.  Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort.

Authors:  Julio Bobes; Celso Arango; Margarida Garcia-Garcia; Javier Rejas
Journal:  Schizophr Res       Date:  2010-03-09       Impact factor: 4.939

6.  Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline.

Authors:  Henry A Nasrallah; Jonathan M Meyer; Donald C Goff; Joseph P McEvoy; Sonia M Davis; T Scott Stroup; Jeffrey A Lieberman
Journal:  Schizophr Res       Date:  2006-08-01       Impact factor: 4.939

Review 7.  Do guidelines for severe mental illness promote physical health and well-being?

Authors:  Leslie Citrome; David Yeomans
Journal:  J Psychopharmacol       Date:  2005-11       Impact factor: 4.153

8.  The Health and Recovery Peer (HARP) Program: a peer-led intervention to improve medical self-management for persons with serious mental illness.

Authors:  Benjamin G Druss; Liping Zhao; Silke A von Esenwein; Joseph R Bona; Larry Fricks; Sherry Jenkins-Tucker; Evelina Sterling; Ralph Diclemente; Kate Lorig
Journal:  Schizophr Res       Date:  2010-02-25       Impact factor: 4.939

9.  Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.

Authors:  Joo-Cheol Shim; Jae-Goo K Shin; Deanna L Kelly; Do-Un Jung; Young-Soo Seo; Kwang-Hyeon Liu; Ji-Hong Shon; Robert R Conley
Journal:  Am J Psychiatry       Date:  2007-09       Impact factor: 18.112

Review 10.  Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia.

Authors:  A H Barnett; P Mackin; I Chaudhry; A Farooqi; R Gadsby; A Heald; J Hill; H Millar; R Peveler; A Rees; V Singh; D Taylor; J Vora; P B Jones
Journal:  J Psychopharmacol       Date:  2007-06       Impact factor: 4.153

View more
  204 in total

Review 1.  Frequency and Nature of Medication Errors and Adverse Drug Events in Mental Health Hospitals: a Systematic Review.

Authors:  Ghadah H Alshehri; Richard N Keers; Darren M Ashcroft
Journal:  Drug Saf       Date:  2017-10       Impact factor: 5.606

2.  Papers and documents available on the WPA website.

Authors: 
Journal:  World Psychiatry       Date:  2012-02       Impact factor: 49.548

3.  Report on the implementation of the WPA Action Plan 2008-2011.

Authors:  Mario Maj
Journal:  World Psychiatry       Date:  2011-10       Impact factor: 49.548

4.  Prevalence of the metabolic syndrome in patients with borderline personality disorder: results from a cross-sectional study.

Authors:  Kai G Kahl; Wiebke Greggersen; Ulrich Schweiger; Joachim Cordes; Christoph U Correll; Helge Frieling; Chakrapani Balijepalli; Christian Lösch; Susanne Moebus
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-07-10       Impact factor: 5.270

5.  The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials.

Authors:  Davy Vancampfort; Joseph Firth; Christoph U Correll; Marco Solmi; Dan Siskind; Marc De Hert; Rebekah Carney; Ai Koyanagi; André F Carvalho; Fiona Gaughran; Brendon Stubbs
Journal:  World Psychiatry       Date:  2019-02       Impact factor: 49.548

6.  A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls.

Authors:  Davy Vancampfort; Martien Wampers; Alex J Mitchell; Christoph U Correll; Amber De Herdt; Michel Probst; Marc De Hert
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

7.  Psychotic symptoms are associated with physical health problems independently of a mental disorder diagnosis: results from the WHO World Health Survey.

Authors:  Carmen Moreno; Roberto Nuevo; Somnath Chatterji; Emese Verdes; Celso Arango; José Luis Ayuso-Mateos
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

8.  Health Care and Mortality among Persons with Severe Mental Illness.

Authors:  Gilad Gal; Hanan Munitz; Itzhak Levav
Journal:  Can J Psychiatry       Date:  2016-09-24       Impact factor: 4.356

Review 9.  Cardiovascular disease in patients with severe mental illness.

Authors:  René Ernst Nielsen; Jytte Banner; Svend Eggert Jensen
Journal:  Nat Rev Cardiol       Date:  2020-10-30       Impact factor: 32.419

10.  The clinical characterization of the adult patient with depression aimed at personalization of management.

Authors:  Mario Maj; Dan J Stein; Gordon Parker; Mark Zimmerman; Giovanni A Fava; Marc De Hert; Koen Demyttenaere; Roger S McIntyre; Thomas Widiger; Hans-Ulrich Wittchen
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.